‹ All Posts
Shaly Gupta

24th Mar 2025 · SEBI-Registered Analyst

Alembic Pharma

APLLTD
Alembic Pharma: US FDA completes inspection of company’s API-III facility at Karakhadi, issues zero form 483 observation (Positive) Attached chart , stock is making morning star pattern that perfectly works.

#Today’sTradingSetup#StockInNews#TechnicalViews#FundamentalViews#EquityResearch
APLLTD_2025-03-24_21-26-07.png
189 likes·35 comments